Funding for this research was provided by:
Fonds De La Recherche Scientifique - FNRS (Senior research associate)
Received: 5 December 2022
Accepted: 20 January 2023
First Online: 13 February 2023
: The scientific board of the ALWP of the EBMT approved this research project. The study was conducted according to the Declaration of Helsinki, and Good Clinical Practice guidelines. EBMT centres commit to obtain informed consent according to the local regulations applicable at the time of transplantation and report pseudonymized data to the EBMT.
: Not applicable.
: FB has received travel grants and/or speaker honoraria from Pfizer, Celgene, Abbvie, Novartis and Sanofi. The other authors declare that they have no relevant conflict of interest.